{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T19:34:16Z","timestamp":1785094456897,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Instruction, University and Research"},{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Telethon","award":["GGP15113"],"award-info":[{"award-number":["GGP15113"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.neuropharm.2017.04.029","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T05:00:50Z","timestamp":1492578050000},"page":"49-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Effects of natural and synthetic isothiocyanate-based H 2 S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8374-4432","authenticated-orcid":false,"given":"Lorenzo","family":"Di Cesare Mannelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Lucarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Micheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Ambrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Virginia","family":"Soldovieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Testai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Taglialatela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Calderone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.04.029_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12990-015-0048-8","article-title":"KCNQ channels in nociceptive cold-sensing trigeminal ganglion neurons as therapeutic targets for treating orofacial cold hyperalgesia","volume":"11","author":"Abd-Elsayed","year":"2015","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1523\/JNEUROSCI.16-03-01066.1996","article-title":"The possible role of hydrogen sulfide as an endogenous neuromodulator","volume":"16","author":"Abe","year":"1996","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib3","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/SHK.0000000000000478","article-title":"AP39, a mitochondrially targeted hydrogen sulfide donor, exerts protective effects in renal epithelial cells subjected to oxidative stress in\u00a0vitro and in acute renal injury in\u00a0vivo","volume":"45","author":"Ahmad","year":"2016","journal-title":"Shock"},{"issue":"9","key":"10.1016\/j.neuropharm.2017.04.029_bib4","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.bbadis.2015.06.012","article-title":"Epilepsy-causing mutations in Kv7.2 C-terminus affect binding and functional modulation by calmodulin","volume":"1852","author":"Ambrosino","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib5","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s00520-014-2242-z","article-title":"A\u00a0systematic review on chronic oxaliplatin-induced peripheral neuropathy and the relation with oxaliplatin administration","volume":"22","author":"Beijers","year":"2014","journal-title":"Support Care Cancer"},{"issue":"2","key":"10.1016\/j.neuropharm.2017.04.029_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(02)02924-2","article-title":"The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain","volume":"460","author":"Blackburn-Munro","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib7","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/j.1476-5381.2009.00111.x","article-title":"Neural KCNQ (kv7) channels","volume":"156","author":"Brown","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2017.04.029_bib8","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/j.pain.0000000000000368","article-title":"Potassium channels in neuropathic pain: advances, challenges, and emerging ideas","volume":"157","author":"Busserolles","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib9","article-title":"Benign familial neonatal convulsions caused by altered gating of KCNQ2\/KCNQ3 potassium channels","volume":"15","author":"Castaldo","year":"2002","journal-title":"J.\u00a0Neurosci."},{"issue":"18","key":"10.1016\/j.neuropharm.2017.04.029_bib10","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/S0959-8049(01)00300-8","article-title":"Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat","volume":"37","author":"Cavaletti","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1055\/s-0034-1368591","article-title":"Hydrogen sulfide releasing capacity of natural isothiocyanates: is it a reliable explanation for the multiple biological effects of Brassicaceae?","volume":"80","author":"Citi","year":"2014","journal-title":"Planta Med."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2015.08.002","article-title":"A\u00a0model of neuropathic pain induced by sorafenib in the rat: effect of dimiracetam","volume":"50","author":"Di Cesare Mannelli","year":"2015","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.1016\/j.neuropharm.2017.04.029_bib13","doi-asserted-by":"crossref","first-page":"e0128080","DOI":"10.1371\/journal.pone.0128080","article-title":"Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity","volume":"10","author":"Di Cesare Mannelli","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.neuropharm.2017.04.029_bib14","first-page":"1585","article-title":"Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain","volume":"14","author":"Di Cesare Mannelli","year":"2013","journal-title":"J.\u00a0Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2017.04.029_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1124\/jpet.105.091595","article-title":"Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels","volume":"316","author":"Distrutti","year":"2006","journal-title":"IPJ Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pain.2004.01.021","article-title":"Taxol-induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients","volume":"109","author":"Dougherty","year":"2004","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.neuropharm.2017.04.029_bib17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/1570159X113119990042","article-title":"Potassium channels in peripheral pain pathways: expression, function and therapeutic potential","volume":"11","author":"Du","year":"2013","journal-title":"Curr. Neuropharmacol."},{"issue":"13","key":"10.1016\/j.neuropharm.2017.04.029_bib18","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1096\/fj.05-3724fje","article-title":"Cystathionine \u03b2-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia\/astrocyte lineage of developing mouse CNS","volume":"19","author":"Enokido","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuropharm.2014.01.029","article-title":"Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain","volume":"81","author":"Fariello","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib20","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1038\/sj.emboj.7601374","article-title":"Oxidative modification of M-type K(+) channels as a mechanism of cytoprotective neuronal silencing","volume":"25","author":"Gamper","year":"2006","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.04.029_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/ars.2007.1656","article-title":"Hydrogen sulfide raises cytosolic calcium in neurons through activation of L-type Ca2+ channels","volume":"10","author":"Garcia Bereguiain","year":"2008","journal-title":"Antiox. Redox. Signal"},{"issue":"3","key":"10.1016\/j.neuropharm.2017.04.029_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/sj.bjp.0703086","article-title":"Differential tetraethylammonium sensitivity of KCNQ1-4 potassium channels","volume":"129","author":"Hadley","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1744-8069-10-15","article-title":"Activation of peripheral KCNQ channels attenuates inflammatory pain","volume":"10","author":"Hayashi","year":"2014","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib24","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1200\/JCO.2013.54.0914","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: american Society of Clinical Oncology clinical practice guideline","volume":"32","author":"Hershman","year":"2014","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1124\/jpet.111.187401","article-title":"Etodolac, a cyclooxygenase-2 inhibitor, attenuates paclitaxel-induced peripheral neuropathy in a mousemodel of mechanical allodynia","volume":"342","author":"Ito","year":"2012","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2015.11.001","article-title":"Celecoxib reverts oxaliplatin-induced neuropathic pain through inhibiting PI3K\/Akt2 pathway in the mouse dorsal root ganglion","volume":"275","author":"Jiang","year":"2016","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/bs.mie.2014.11.025","article-title":"Role of hydrogen sulfide in brain synaptic remodeling","volume":"555","author":"Kamat","year":"2015","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.niox.2014.11.014","article-title":"Inhaled hydrogen sulfide prevents neuropathic pain after peripheral nerve injury in mice","volume":"46","author":"Kida","year":"2015","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib29","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1002\/cne.23019","article-title":"Kv7.5 is the primary Kv7 subunit expressed in C-fibers","volume":"520","author":"King","year":"2012","journal-title":"J.\u00a0Comp. Neurol."},{"issue":"8","key":"10.1016\/j.neuropharm.2017.04.029_bib30","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.neuropharm.2008.04.006","article-title":"Retigabine reduces the excitability of unmyelinated peripheral human axons","volume":"54","author":"Lang","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib31","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/glia.20362","article-title":"Hydrogen sulphide regulates calcium homeostasis in microglial cells","volume":"54","author":"Lee","year":"2006","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib32","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1161\/CIRCULATIONAHA.107.753467","article-title":"Characterization of a novel, water-soluble hydrogen sulfide-releasing molecule (GYY4137): new insights into the biology of hydrogen sulfide","volume":"117","author":"Li","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib33","doi-asserted-by":"crossref","first-page":"514898","DOI":"10.1155\/2014\/514898","article-title":"Sodium hydrosulfide relieves neuropathic pain in chronic constriction injured rats","volume":"2014","author":"Lin","year":"2014","journal-title":"Evid. Based. Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.04.029_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.phrs.2012.12.005","article-title":"Vasorelaxation by hydrogen sulphide involves activation of Kv 7 potassium channels","volume":"70","author":"Martelli","year":"2013","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.neuropharm.2017.04.029_bib35","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1021\/ml400239a","article-title":"Arylthioamides as H2S donors: l-cysteine-activated releasing properties and vascular effects in\u00a0vitro and in\u00a0vivo","volume":"4","author":"Martelli","year":"2013","journal-title":"ACS Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.04.029_bib36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.vph.2013.11.003","article-title":"Pharmacological characterization of the vascular effects of aryl isothiocyanates: is hydrogen sulfide the real player?","volume":"60","author":"Martelli","year":"2014","journal-title":"Vasc. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2017.04.029_bib37","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1523\/JNEUROSCI.3143-03.2004","article-title":"M\u00a0channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals","volume":"24","author":"Martire","year":"2004","journal-title":"J.\u00a0Neurosci."},{"issue":"13","key":"10.1016\/j.neuropharm.2017.04.029_bib38","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"11","key":"10.1016\/j.neuropharm.2017.04.029_bib39","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1073\/pnas.1216867110","article-title":"Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits","volume":"110","author":"Miceli","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.04.029_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coph.2007.10.003","article-title":"Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs","volume":"8","author":"Miceli","year":"2008","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib41","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/978-3-319-18144-8_10","article-title":"Brain, learning, and memory: role of H2S in neurodegenerative diseases","volume":"230","author":"Nagpure","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuropharm.2017.04.029_bib42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neulet.2011.09.013","article-title":"Neuroprotective effects of Kv7 channel agonist, retigabine, for cisplatin-induced peripheral neuropathy","volume":"505","author":"Nodera","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib43","first-page":"497","article-title":"Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure","volume":"192","author":"O'Callaghan","year":"1975","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib44","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1523\/JNEUROSCI.23-18-07227.2003","article-title":"KCNQ\/M currents in sensory neurons: significance for pain therapy","volume":"23","author":"Passmore","year":"2003","journal-title":"J.\u00a0Neurosci."},{"issue":"11","key":"10.1016\/j.neuropharm.2017.04.029_bib45","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.tibs.2015.08.007","article-title":"H2S: a novel gasotransmitter that signals by sulfhydration","volume":"40","author":"Paul","year":"2015","journal-title":"Trends biochem. Sci."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/ars.2010.3698","article-title":"Hydrogen sulfide and hemeproteins: knowledge and mysteries","volume":"15","author":"Pietri","year":"2011","journal-title":"Antioxid. Redox. Signal"},{"issue":"3","key":"10.1016\/j.neuropharm.2017.04.029_bib47","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0304-3959(01)00363-3","article-title":"A\u00a0painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel","volume":"94","author":"Polomano","year":"2001","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.neuropharm.2017.04.029_bib48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1124\/jpet.103.060582","article-title":"Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain","volume":"309","author":"Rashid","year":"2004","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"issue":"8","key":"10.1016\/j.neuropharm.2017.04.029_bib49","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1023\/A:1018851723920","article-title":"Colonic sulfide in pathogenesis and treatment of ulcerative colitis","volume":"42","author":"Roediger","year":"1997","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib50","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.pain.2010.12.028","article-title":"Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury","volume":"152","author":"Rose","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib51","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1097\/HJH.0b013e32833c20d5","article-title":"Systemic peripheral artery relaxation by KCNQ channel openers and hydrogen sulfide","volume":"28","author":"Schleifenbaum","year":"2010","journal-title":"J.\u00a0Hypertens."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2017.04.029_bib52","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1113\/jphysiol.2006.106815","article-title":"KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier","volume":"573","author":"Schwarz","year":"2006","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib53","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1089\/ars.2008.2253","article-title":"3-Mercaptopyruvate sulfurtransferease produces hydrogen sulfide and bound sulfane sulfur in the brain","volume":"11","author":"Shibuya","year":"2009","journal-title":"Antioxid. Redox. Signal"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib54","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neuro.2010.07.006","article-title":"Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in\u00a0vitro model of oxaliplatin-induced acute neuropathy","volume":"31","author":"Sittl","year":"2010","journal-title":"Neurotoxicology"},{"issue":"18","key":"10.1016\/j.neuropharm.2017.04.029_bib55","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1523\/JNEUROSCI.0580-07.2007","article-title":"Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions","volume":"27","author":"Soldovieri","year":"2007","journal-title":"J.\u00a0Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2017.04.029_bib56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1152\/physiol.00009.2011","article-title":"Driving with no brakes: molecular pathophysiology of Kv7 potassium channels","volume":"26","author":"Soldovieri","year":"2011","journal-title":"Physiol. (Bethesda)"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib57","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.2002.08.015","article-title":"Triplet combination with irinotecan plus oxaliplatin plus continuous-infusion fluorouracil and leucovorin as first-line treatment in metastatic colorectal cancer: a multicenter phase II trial","volume":"20","author":"Souglakos","year":"2002","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib58","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nrd2425","article-title":"Hydrogen sulphide and its therapeutic potential","volume":"6","author":"Szab\u00f3","year":"2007","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib59","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/bph.12369","article-title":"Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms","volume":"171","author":"Szab\u00f2","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1744-8069-5-9","article-title":"Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli","volume":"5","author":"Ta","year":"2009","journal-title":"Mol. Pain"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib61","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-3-319-18144-8_11","article-title":"H2S and pain: a novel aspect for processing of somatic, visceral and neuropathic pain signals","volume":"230","author":"Terada","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.04.029_bib62","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/cvr\/cvv281","article-title":"Expression and function of Kv7. 4 channels in Rat cardiac mitochondria: possible targets for cardioprotection","volume":"110","author":"Testai","year":"2015","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.neuropharm.2017.04.029_bib63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrd4433","article-title":"Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter","volume":"14","author":"Wallace","year":"2015","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"13","key":"10.1016\/j.neuropharm.2017.04.029_bib64","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1096\/fj.02-0211hyp","article-title":"Two's company, three\u2019sa crowd: can H2S be the third endogenous gaseous transmitter?","volume":"16","author":"Wang","year":"2002","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.neuropharm.2017.04.029_bib65","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/aps.2015.131","article-title":"KCNQ potassium channels in sensory system and neural circuits","volume":"37","author":"Wang","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"5395","key":"10.1016\/j.neuropharm.2017.04.029_bib66","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1126\/science.282.5395.1890","article-title":"KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel","volume":"282","author":"Wang","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.04.029_bib67","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/bph.12439","article-title":"Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy","volume":"171","author":"Ward","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib68","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1248\/bpb.34.1377","article-title":"Antinociceptive efficacy of verticinone in murine models of inflammatory pain and paclitaxel induced neuropathic pain","volume":"34","author":"Xu","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.neuropharm.2017.04.029_bib69","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1039\/C4CC00968A","article-title":"Hydrogen sulfide (H2S) releasing agents: chemistry and biological applications","volume":"50","author":"Zhao","year":"2014","journal-title":"Chem. Commun."},{"issue":"6","key":"10.1016\/j.neuropharm.2017.04.029_bib70","doi-asserted-by":"crossref","first-page":"e67322","DOI":"10.1371\/journal.pone.0067322","article-title":"Brain 3-mercaptopyruvate sulfurtransferase (3MST): cellular localization and downregulation after acute stroke","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.neuropharm.2017.04.029_bib71","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.pain.2012.12.005","article-title":"Suppression of KCNQ\/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model","volume":"154","author":"Zheng","year":"2013","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.neuropharm.2017.04.029_bib72","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.apsb.2015.06.004","article-title":"Hydrogen sulfide prodrugs\u2014a review","volume":"5","author":"Zheng","year":"2015","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081730179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081730179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T20:27:20Z","timestamp":1589747240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081730179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":72,"alternative-id":["S002839081730179X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.029","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}